New Exercise and Fitness Review
Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriv
Background
elayed onset muscle soreness (DOMS) due to eccentric muscle activity is associated with inflammatory responses and production of reactive oxygen species (ROS) that sustain both inflammation and oxidative stress. Curcumin, a powerful promoter of anti-oxidant response, is one of the best-investigated natural products, and is now commercially available as a lecithin delivery system (Meriva®, Indena SpA, Milan) with improved bio-availability. The aim of this study was to test whether curcumin could attenuate damage from oxidative stress and inflammation related to acute muscle injury induced by eccentric continuous exerciseMethods:This was a randomised, placebo-controlled, single-blind pilot trial. Twenty male healthy, moderately active volunteers were randomised to curcumin given as the Phytosome® delivery system 1.g twice daily (200.mg curcumin b.i.d.) or matching placebo. Supplementation was initiated 48.hours prior to a downhill running test and was continued for 24.hours after the test (4.days in total). Muscle damage was quantified by magnetic resonance imaging, laboratory tests and histological analyses on muscle samples obtained 48.hours after the test. Patient-reported pain intensity was also recorded.Results:Subjects in the curcumin group reported less pain in the lower limb as compared with subjects in the placebo group, although significant differences were observed only for the right and left anterior thighs. Significantly fewer subjects in the curcumin group had MRI evidence of muscle injury in the posterior or medial compartment of both thighs. Increases in markers of muscle damage and inflammation tended to be lower in the curcumin group, but significant differences were only observed for interleukin-8 at 2.h after exercise. No differences in markers of oxidative stress and muscle histology were observedConclusions:Curcumin has the potential for preventing DOMS, as suggested by its effects on pain intensity and muscle injury. Larger studies are needed to confirm these results and further clarify the mechanism of action of curcumin.
elayed onset muscle soreness (DOMS) due to eccentric muscle activity is associated with inflammatory responses and production of reactive oxygen species (ROS) that sustain both inflammation and oxidative stress. Curcumin, a powerful promoter of anti-oxidant response, is one of the best-investigated natural products, and is now commercially available as a lecithin delivery system (Meriva®, Indena SpA, Milan) with improved bio-availability. The aim of this study was to test whether curcumin could attenuate damage from oxidative stress and inflammation related to acute muscle injury induced by eccentric continuous exerciseMethods:This was a randomised, placebo-controlled, single-blind pilot trial. Twenty male healthy, moderately active volunteers were randomised to curcumin given as the Phytosome® delivery system 1.g twice daily (200.mg curcumin b.i.d.) or matching placebo. Supplementation was initiated 48.hours prior to a downhill running test and was continued for 24.hours after the test (4.days in total). Muscle damage was quantified by magnetic resonance imaging, laboratory tests and histological analyses on muscle samples obtained 48.hours after the test. Patient-reported pain intensity was also recorded.Results:Subjects in the curcumin group reported less pain in the lower limb as compared with subjects in the placebo group, although significant differences were observed only for the right and left anterior thighs. Significantly fewer subjects in the curcumin group had MRI evidence of muscle injury in the posterior or medial compartment of both thighs. Increases in markers of muscle damage and inflammation tended to be lower in the curcumin group, but significant differences were only observed for interleukin-8 at 2.h after exercise. No differences in markers of oxidative stress and muscle histology were observedConclusions:Curcumin has the potential for preventing DOMS, as suggested by its effects on pain intensity and muscle injury. Larger studies are needed to confirm these results and further clarify the mechanism of action of curcumin.This has been an automated posting
__________________
W C B B Sponsors
Truepeptide30off
Peptides411
ElitePeptides
Androgenetx
BlueSkyPeptidebluesky20
Maxim Peptides
The Chem Depot- For all your research chemical needs
Southern SARMsWCBB10 for 10% off ALL products
Species Nutrition
PHF Supplements
All About Peptides
Evolution PeptidesWCBB15 at checkout and get 15% off available items!
W C B B Sponsors
Truepeptide30off
Peptides411
ElitePeptides
Androgenetx
BlueSkyPeptidebluesky20
Maxim Peptides
The Chem Depot- For all your research chemical needs
Southern SARMsWCBB10 for 10% off ALL products
Species Nutrition
PHF Supplements
All About Peptides
Evolution PeptidesWCBB15 at checkout and get 15% off available items!
Featured Sponsor Of the Month
Remember… Any advice given on this board is just an opinion and not to be taken as medical advice. WCBB doesn’t advocate or condone use of steroids. Check the laws in your country. WCBB just provides the platform inwhich to discuss such matters
World Class Bodybuilding Forum
Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriv
No comments:
Post a Comment